South and Central America Microcatheters Market is expected to reach US$ 37.03 Mn by 2027


PRESS RELEASE BY The Insight Partners 05 May 2021

Share this press on


The coronary segment by indication is estimated to lead the market growth during the forecast period.

According to The Insight Partners market research study of “South and Central America Microcatheters Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Indication, End User and Country.” The South and Central America microcatheters market is expected to reach US$ 37.03 million by 2027 from US$ 20.86 million in 2019; it is estimated to grow at a CAGR of 7.5% from 2020 to 2027. The report highlights trends prevailing in the South and Central America microcatheters market and the factors driving market along with those that act as hindrances.

The South and Central America microcatheters market, by indication, is segmented into, neurovascular, coronary, and general peripheral vascular. The coronary segment held the largest share of the market in 2019, and the same segment is anticipated to register the highest CAGR in the market during the forecast period. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the most prominent cause of morbidity and mortality across the world. The CVDs include cerebrovascular disease, coronary heart disease, rheumatic heart disease, and so on. As per the WHO data published in 2017, ~17.9 million people died from CVDs in 2016, which was 31.0% of all the global deaths in that year. Therefore, the significantly rising incidence of CVDs across Latin America is likely to propel the demand for devices, such as microcatheters, that are required to treat these diseases. In addition, in the recent years, the prevalence of neurological disorders such as cerebral aneurysm has increased significantly across South and Central America, which fueled the demand for microcatheters used in their treatment procedures. Also, the rising geriatric population leads to rise in cardiovascular disease and neurological disease, which is contributing to the growth of the South and Central America microcatheters market.

Countries in South and Central America are facing economic and humanitarian challenges due to the increasing incidence of COVID-19. They have responded to the outbreak by closing borders, ordering quarantines, avoiding alternative surgery procedures, and imposing a host of restrictions to keep people confined at home. Preventive measures such as social distancing and lockdown are significantly reducing the visits of people to the healthcare facilities, which, in turn, is hampering the growth of the microcatheters market in South and Central America.

The growth of the market is attributed to some key driving factors such as significantly increasing prevalence of chronic disorders like cardiovascular & neurovascular diseases and rising elderly population across South and Central America. However, product recall and stringent regulatory requirement and lack of expert professionals are the major factor hindering the market growth.

Boston Scientific Corporation, Medtronic, Terumo Corporation, Penumbra, Inc, Stryker Corporation and Teleflex Incorporated are among the leading companies operating in the South and Central America microcatheters market.

The report segments in South and Central America Microcatheters Market as follows:

By Indication

  • Neurovascular
  • Coronary
  • General Peripheral Vascular

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

By Country

  • Brazil
  • Argentina
  • Rest of South and Central America

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com
Download Free PDF Brochure